Welcome to Arimidex.net
This website is an international information resource for healthcare professionals with an interest in breast cancer. This website is not intended to replace the advice of a qualified healthcare professional.
- If you are a healthcare professional in the US, you should visit Arimidex US
- If you are a healthcare professional in the UK, you should visit the AstraZeneca UK site
If you are a healthcare professional in Germany, you should visit the Arimidex Germany site
- If you are a patient, you should visit the Patient site
- If you are a journalist, you should visit the AstraZeneca Press Office
- If your country is not listed, you should visit www.AstraZeneca.com
Arimidex (anastrozole) is a potent and highly selective non-steroidal aromatase inhibitor, indicated for the following:
- Adjuvant treatment of hormone receptor-positive early invasive breast cancer in postmenopausal women
- Adjuvant treatment of early breast cancer in hormone receptor-positive postmenopausal women who have received 2 to 3 years of adjuvant tamoxifen
- Treatment of advanced breast cancer in postmenopausal women
Please consult local Prescribing Information for Arimidex before use.
Information
This website has been produced in accordance with both the ABPI Code of Practice for the Pharmaceutical Industry 2008 and the EFPIA Code on the Promotion of Prescription-only Medicines to, and interactions with, Healthcare Professionals. |
